Showing results (1131-1140 of 1,322) with videos related to

Sort By:
Pageof 133
Annals of Surgery|March 4, 2017
Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study GroupSjoerd Nell, Helena M Verkooijen, Carolina R C Pieterman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2014
Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patientsJoanne M de Laat, Carolina R Pieterman, Medard F van den Broek, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosisSavvina Prapiadou, Luka Živković, Barbara Thorand, et al.
The Veterinary Record|April 23, 2021
Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmissionMargaret J Hosie, Ilaria Epifano, Vanessa Herder, et al.
Global Health Action|June 12, 2025
Student experiences and perspectives on decolonising global health education: a qualitative study across five Nordic countriesJennifer J Infanti, Jessica Omija Korpela, Chloe Maria Stephenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomographyAstrid A M van der Veldt, Mark Lubberink, Ron H J Mathijssen, et al.
Lancet (London, England)|June 8, 2024
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 studySimron Singh, Daniel Halperin, Sten Myrehaug, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trialM H Kulke, P Ruszniewski, E Van Cutsem, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2016
Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study GroupRachel S van Leeuwaarde, Bernadette P M van Nesselrooij, Ad R Hermus, et al.
Circulation|December 28, 2023
Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on AtherosclerosisSavvina Prapiadou, Luka Živković, Barbara Thorand, et al.
Pageof 133